108 results found

A recent decision by Brazil's Federal Regional Court of the 1st Region confirms that the Ministry of Agriculture holds final authority over agrochemical use decisions following environmental assessments by Ibama. This ruling addresses regulatory inconsistencies in the re-evaluation process of active ingredients, particularly regarding imidacloprid, and establishes that uniform treatment must apply to both registered products and new registration requests.

O debate sobre a instituição de um mecanismo de Patent Term Adjustment (PTA) no Brasil divide o INPI e o setor privado, com propostas legislativas buscando compensar titulares quando o instituto atrasar na análise de pedidos de patente. Enquanto o INPI argumenta que seus tempos médios atuais de análise tornam o PTA desnecessário, especialistas apontam que países líderes em inovação como EUA, Japão e China adotam o mecanismo justamente para proteger inve

A flexibilização procedimental no processo civil brasileiro permite antecipar a produção de prova pericial em ações de infração de patente, equilibrando garantias processuais como contraditório, eficiência e duração razoável. Essa prática, já adotada pelas Varas Empresariais do Rio de Janeiro, possibilita decisões mais rápidas sobre tutelas provisórias, protegendo direitos de propriedade industrial e evitando danos irr

Brazil's new Digital Child and Adolescent Statute fundamentally reshapes how technology platforms must protect minors online, imposing strict age verification requirements...

Brazil has built a comprehensive legal framework to combat money laundering and terrorist financing, anchored by Law #9,613/98 and strengthened by Central Bank Circular #3,978/2020. The Financial Activities Control Council (COAF) serves as the nation's intelligence hub, analyzing 87 distinct laundering typologies that span corporate structures, cryptocurrency transactions, real estate schemes, and cash-based operations. Understanding these regulatory mechanisms and criminal patterns is essential for financi

Brazil's life sciences regulatory framework combines centralized federal oversight through ANVISA with a comprehensive legal structure governing medicinal products, biologicals, medical devices...